Mirum Pharmaceuticals, Inc. (MIRM)
USD 39.59
(0.03%)
USD 39.59
(0.03%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 139.33 Million USD | 114.89% |
| 2022 | 64.68 Million USD | 275.33% |
| 2021 | 17.23 Million USD | 2866.45% |
| 2020 | -623 Thousand USD | -92.28% |
| 2019 | -324 Thousand USD | 0.0% |
| 2018 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 57.49 Million USD | 12.17% |
| 2024 Q1 | 51.39 Million USD | 9.46% |
| 2023 Q4 | 46.95 Million USD | 25.21% |
| 2023 FY | 139 Million USD | 114.89% |
| 2023 Q3 | 37.49 Million USD | 22.2% |
| 2023 Q2 | 30.68 Million USD | 15.27% |
| 2023 Q1 | 26.61 Million USD | 13.7% |
| 2022 Q2 | 14.96 Million USD | 42.91% |
| 2022 Q1 | 10.46 Million USD | 747.61% |
| 2022 Q3 | 15.84 Million USD | 5.94% |
| 2022 FY | 64.68 Million USD | 275.33% |
| 2022 Q4 | 23.41 Million USD | 47.73% |
| 2021 Q1 | -185 Thousand USD | 0.0% |
| 2021 Q2 | 11 Million USD | 6045.95% |
| 2021 Q3 | 5 Million USD | -54.55% |
| 2021 Q4 | 1.23 Million USD | -75.3% |
| 2021 FY | 17.23 Million USD | 2866.45% |
| 2020 FY | -623 Thousand USD | -92.28% |
| 2020 Q4 | - USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2020 Q2 | - USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 FY | -324 Thousand USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Agenus Inc. | 139.61 Million USD | 0.201% |
| Immix Biopharma, Inc. | -5468.00 USD | 2548289.466% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 21084.187% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 279.56% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 26539.279% |
| MiMedx Group, Inc. | 266.84 Million USD | 47.784% |
| Novavax, Inc. | 639.93 Million USD | 78.227% |
| Seer, Inc. | 7.02 Million USD | -1882.852% |
| Acelyrin, Inc. | -115 Thousand USD | 121260.87% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -3.006% |
| IO Biotech, Inc. | -756 Thousand USD | 18530.556% |
| Ardelyx, Inc. | 106.66 Million USD | -30.634% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 243.718% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 547.05% |
| Fortress Biotech, Inc. | 57.85 Million USD | -140.843% |
| Fortress Biotech, Inc. | 57.85 Million USD | -140.843% |
| Geron Corporation | -123.5 Million USD | 212.819% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 42.121% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -740.532% |
| Incyte Corporation | 3.44 Billion USD | 95.95% |
| Innoviva, Inc. | 261.06 Million USD | 46.628% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 253436.364% |
| ChromaDex Corporation | 50.78 Million USD | -174.39% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -16.352% |
| MEI Pharma, Inc. | 49.32 Million USD | -182.472% |
| NextCure, Inc. | -3.68 Million USD | 3882.166% |
| Onconetix, Inc. | -1.12 Million USD | 12461.544% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 580.996% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 97332.399% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 231.296% |
| Vaxcyte, Inc. | -75 Million USD | 285.78% |
| Precigen, Inc. | 106 Thousand USD | -131348.113% |
| Pharming Group N.V. | 220.1 Million USD | 36.696% |
| ContextLogic Inc. | 59 Million USD | -136.161% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 60158.19% |
| Pyxis Oncology, Inc. | -2 Million USD | 7066.75% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -26.931% |
| AlloVir, Inc. | -398 Thousand USD | 35108.794% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -379.556% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 1386379.972% |
| Summit Therapeutics Inc. | -2.05 Million USD | 6896.829% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 1161225.0% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 24501.926% |
| Senti Biosciences, Inc. | -2.68 Million USD | 5293.254% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -116012.5% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 3004.023% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -378.338% |
| Psyence Biomedical Ltd. | -240.00 USD | 58056350.0% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 315423.165% |
| Chimerix, Inc. | 324 Thousand USD | -42904.63% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 243157.252% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 170020.732% |
| CRISPR Therapeutics AG | 240.95 Million USD | 42.174% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -33.849% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -26955.34% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -13709.217% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 3873.971% |
| Precision BioSciences, Inc. | 40.47 Million USD | -244.275% |
| Dyadic International, Inc. | 922.95 Thousand USD | -14996.586% |
| Elevation Oncology, Inc. | -39 Thousand USD | 357369.231% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -561.578% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -15.656% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 90.82% |
| Aptorum Group Limited | -1.11 Million USD | 12599.91% |
| Bicycle Therapeutics plc | -129.52 Million USD | 207.578% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 3634.584% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -1670.232% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 1143.095% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Alkermes plc | 1.37 Billion USD | 89.864% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -3082.618% |
| Jaguar Health, Inc. | 7.72 Million USD | -1703.923% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -27991.734% |
| AbCellera Biologics Inc. | 38.02 Million USD | -266.43% |
| PureTech Health plc | -1.6 Million USD | 8792.14% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 27063.924% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 407.413% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -17273.441% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -546.716% |
| AnaptysBio, Inc. | 14.78 Million USD | -842.663% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 707.945% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 117691.209% |
| Molecular Templates, Inc. | 50.39 Million USD | -176.486% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -374.138% |
| Vaxxinity, Inc. | -2.23 Million USD | 6337.019% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 28420.122% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 733.715% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 397.476% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 14779.606% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 2786800.0% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -3339.521% |
| ImmuCell Corporation | 4.39 Million USD | -3069.381% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 79791.495% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -32762.028% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -631.686% |
| Opthea Limited | 21.72 Thousand USD | -641405.525% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 176.808% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 241.864% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 241.942% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -22779.31% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 55.579% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -5313.17% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 274705.834% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 2063.018% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 29461.81% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 1339859.615% |
| Soligenix, Inc. | 97.31 Thousand USD | -143085.251% |
| Century Therapeutics, Inc. | -10.8 Million USD | 1389.065% |
| Kura Oncology, Inc. | -849 Thousand USD | 16511.661% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 307.64% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 94885.714% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -40.687% |
| Autolus Therapeutics plc | -4.86 Million USD | 2962.852% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -236.672% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 83037.5% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -47.097% |
| GRI Bio, Inc. | 10.84 Million USD | -1185.26% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -5385.66% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 1703.948% |
| IGM Biosciences, Inc. | -211.66 Million USD | 165.83% |
| INmune Bio, Inc. | 155 Thousand USD | -89793.548% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -124.955% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 9350.205% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 21587.26% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 476068.436% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -34560.448% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 7080.711% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 44615.974% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -47.505% |
| Verastem, Inc. | -62 Thousand USD | 224833.871% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -5622.177% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 53485.057% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -4503.072% |
| Histogen Inc. | 3.76 Million USD | -3596.869% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -24082.589% |
| Surrozen, Inc. | -27.23 Million USD | 611.697% |
| Organovo Holdings, Inc. | -5.38 Million USD | 2685.545% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 11664.222% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 643.28% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -594.868% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 7037221.212% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -2196.823% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 207656.866% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 9.985% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -95465.844% |
| Apollomics, Inc. | 127 Thousand USD | -109612.598% |
| Amarin Corporation plc | 165.54 Million USD | 15.831% |
| Mesoblast Limited | -9.81 Million USD | 1519.613% |
| Turnstone Biologics Corp. | 16.5 Million USD | -744.148% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 226.108% |
| Synaptogenix, Inc. | -6347.00 USD | 2195389.113% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 273305.882% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 13.652% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 92.073% |
| Better Therapeutics, Inc. | -2.72 Million USD | 5205.716% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 224.228% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 58.787% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1221479.734% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 2325.799% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 12675.361% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -1804.004% |
| Insmed Incorporated | 239.63 Million USD | 41.855% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -3794.215% |
| OmniAb, Inc. | 14.66 Million USD | -849.99% |
| Alector, Inc. | -95.05 Million USD | 246.587% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -10.917% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 420.583% |
| Zai Lab Limited | 170.9 Million USD | 18.471% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -70.176% |
| Aura Biosciences, Inc. | -1.29 Million USD | 10859.459% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -107080.769% |
| Immunic, Inc. | -111 Thousand USD | 125627.027% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -778.863% |
| Veracyte, Inc. | 248.14 Million USD | 43.85% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 101.994% |
| FibroGen, Inc. | 128.9 Million USD | -8.092% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 24704887.234% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 1294.278% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 95.9% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -35718.766% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 60.789% |
| TG Therapeutics, Inc. | 219.1 Million USD | 36.408% |
| Galecto, Inc. | -830 Thousand USD | 16887.349% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 10160.289% |
| Fortrea Holdings Inc. | 424 Million USD | 67.138% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 261.703% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 24674.074% |
| XBiotech Inc. | -1.74 Million USD | 8089.392% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 12675.361% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 399.832% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 284.467% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -89.822% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -729.227% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 64.185% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 380.651% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 57.357% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 1330.457% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -469.854% |
| NexImmune, Inc. | -1.02 Million USD | 13694.03% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -2580177.778% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 2060.903% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 98.767% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 208601.055% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 4023.824% |
| Ainos, Inc. | -253.73 Thousand USD | 55014.024% |
| Pluri Inc. | 322 Thousand USD | -43171.739% |
| Prothena Corporation plc | -129.2 Million USD | 207.844% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -176.327% |
| Celularity Inc. | 6.75 Million USD | -1962.694% |
| Rallybio Corporation | -150 Thousand USD | 92990.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | 527.316% |
| MeiraGTx Holdings plc | 287 Thousand USD | -48448.78% |
| Omeros Corporation | -69.77 Million USD | 299.68% |
| Humacyte, Inc. | -76.55 Million USD | 282.018% |
| Immunocore Holdings plc | 248.39 Million USD | 43.905% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 1018.551% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -123.358% |
| Blueprint Medicines Corporation | 236.58 Million USD | 41.105% |
| CalciMedica, Inc. | -58 Thousand USD | 240332.759% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 9871.038% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 4999.262% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 551.434% |
| Pulmatrix, Inc. | -8.22 Million USD | 1795.073% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 12008.974% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 35021.053% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 134.939% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -4920.023% |
| Cytokinetics, Incorporated | -322.59 Million USD | 143.192% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -16062.184% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 40960.704% |
| Vor Biopharma Inc. | -3.49 Million USD | 4090.12% |
| Roivant Sciences Ltd. | 109.23 Million USD | -27.555% |
| Evogene Ltd. | 1.39 Million USD | -9859.614% |
| ProKidney Corp. | -3.16 Million USD | 4496.813% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 417.305% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -1932.011% |
| CorMedix Inc. | -205.56 Thousand USD | 67882.47% |
| BioLineRx Ltd. | 1.1 Million USD | -12475.361% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 277.111% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 422327.273% |
| Atai Life Sciences N.V. | -5000.00 USD | 2786800.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 114441.165% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 145240.625% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 10131.317% |
| Sagimet Biosciences Inc. | 2 Million USD | -6866.75% |
| MediciNova, Inc. | 979.7 Thousand USD | -14122.138% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 265.247% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 147458.68% |
| GeoVax Labs, Inc. | -20.72 Million USD | 772.441% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 43.02% |
| Biomea Fusion, Inc. | -4.2 Million USD | 3416.71% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 84.027% |
| Mereo BioPharma Group plc | 7.42 Million USD | -1776.313% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 45046.774% |
| Absci Corporation | -41.84 Million USD | 432.947% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 2786800.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 282.44% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 5761.723% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 34.809% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 14907.12% |
| Allakos Inc. | -6.14 Million USD | 2368.93% |
| Imunon, Inc. | -720 Thousand USD | 19451.949% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 301.946% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 70.721% |
| BioAtla, Inc. | -103.73 Million USD | 234.323% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1221479.734% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 78378.09% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 157.382% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 44902.251% |
| XOMA Corporation | 3.86 Million USD | -3508.78% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 298.809% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -841.835% |
| aTyr Pharma, Inc. | -2.38 Million USD | 5934.799% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -1018.258% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 480565.517% |
| Viridian Therapeutics, Inc. | -1 Million USD | 13922.917% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -1071807592.308% |
| Akari Therapeutics, Plc | -4000.00 USD | 3483475.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 78.123% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -71461.004% |
| UroGen Pharma Ltd. | 73.35 Million USD | -89.954% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 621.971% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -1200029.199% |
| Orgenesis Inc. | -5.72 Million USD | 2533.799% |
| Entera Bio Ltd. | -56 Thousand USD | 248912.5% |
| GH Research PLC | -315 Thousand USD | 44333.333% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 73822.222% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 26640.0% |
| Xencor, Inc. | -85.26 Million USD | 263.424% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 63154.074% |
| Replimune Group, Inc. | -2.65 Million USD | 5348.023% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 14016.299% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 21.653% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -71461.004% |
| Portage Biotech Inc. | -54 Thousand USD | 258127.778% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 147458.68% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 37058.886% |
| OncoCyte Corporation | 413 Thousand USD | -33637.288% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 3099877.531% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 62763613.514% |
| Purple Biotech Ltd. | -196 Thousand USD | 71189.286% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -1453.691% |
| scPharmaceuticals Inc. | 9.78 Million USD | -1324.402% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 1433.993% |
| HilleVax, Inc. | -2.15 Million USD | 6562.662% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 143744.33% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 928752.359% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 20958.533% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 605904.348% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 1856375.379% |
| Savara Inc. | -44.26 Million USD | 414.796% |
| Curis, Inc. | 9.81 Million USD | -1320.192% |
| Daré Bioscience, Inc. | 2.76 Million USD | -4931.013% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 111757.371% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 8158.704% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 61211.842% |
| BeiGene, Ltd. | 2.07 Billion USD | 93.298% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 5083.547% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 134.863% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -145.793% |
| Erasca, Inc. | -3.73 Million USD | 3833.521% |
| bluebird bio, Inc. | -4.03 Million USD | 3557.444% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 493880.566% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 92.683% |
| DBV Technologies S.A. | 15.72 Million USD | -785.904% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 493880.566% |
| Moderna, Inc. | 2.15 Billion USD | 93.534% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 15327.869% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -1640.382% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 26095.336% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -4.146% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 2339.392% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 454.154% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 225.382% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 3983.361% |
| MacroGenics, Inc. | 50.52 Million USD | -175.763% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 2384.929% |
| Prime Medicine, Inc. | -147.9 Million USD | 194.206% |
| Aditxt, Inc. | -111.66 Thousand USD | 124885.062% |
| Adagene Inc. | 18.11 Million USD | -669.318% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -28452.254% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 0.618% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 11.722% |
| SciSparc Ltd. | 2.19 Million USD | -6244.945% |
| Vericel Corporation | 135.57 Million USD | -2.773% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 556349.75% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 449828.875% |
| Generation Bio Co. | -73.91 Million USD | 288.517% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 31984.439% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -155.104% |
| Invivyd, Inc. | -2.02 Million USD | 6970.562% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 146.315% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 134803.881% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -44.586% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -41.762% |
| ADMA Biologics, Inc. | 88.21 Million USD | -57.944% |
| Clene Inc. | 533 Thousand USD | -26041.651% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -477.933% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 14659.561% |
| GeoVax Labs, Inc. | -20.72 Million USD | 772.441% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -6908.803% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 71805.367% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -179.761% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 2064.679% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 16766.866% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -67.038% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -190477.47% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -162.095% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 180.453% |
| Trevena, Inc. | 1.45 Million USD | -9476.289% |
| Surrozen, Inc. | -27.23 Million USD | 611.697% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 39571.671% |
| Cingulate Inc. | -582.91 Thousand USD | 24003.019% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 449567.742% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 807.32% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 1840720.872% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 15915.551% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 79.531% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 14202.733% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 247402.19% |
| Kronos Bio, Inc. | 1.37 Million USD | -10055.612% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 359.634% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 47817.466% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 28633.894% |
| ImmunityBio, Inc. | -17.89 Million USD | 878.843% |
| Korro Bio, Inc. | -3.63 Million USD | 3938.43% |
| Kineta, Inc. | 5.43 Million USD | -2464.605% |
| BioVie Inc. | -229.37 Thousand USD | 60844.974% |
| Codexis, Inc. | 57.33 Million USD | -143.023% |
| Celularity Inc. | 6.75 Million USD | -1962.694% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -3372.091% |
| Celcuity Inc. | -142.77 Thousand USD | 97692.665% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -275320.043% |
| Cibus, Inc. | 1.42 Million USD | -9698.523% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 37355.348% |
| IN8bio, Inc. | -2.5 Million USD | 5671.172% |
| Kodiak Sciences Inc. | -25.94 Million USD | 636.998% |
| Annexon, Inc. | -3.26 Million USD | 4364.922% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 6916.781% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 433.84% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -21671.094% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 82.102% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 19.439% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 7433.421% |
| Arcellx, Inc. | 108.27 Million USD | -28.681% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 530.458% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -75.919% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 758.732% |
| Moolec Science SA | -143.3 Thousand USD | 97329.685% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 429.257% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -4138.972% |
| Royalty Pharma plc | 1.79 Billion USD | 92.233% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 298.794% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 3857658.14% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -60116.257% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 225.061% |
| Humacyte, Inc. | -76.55 Million USD | 282.018% |
| 89bio, Inc. | -273 Thousand USD | 51138.462% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 11184.726% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 16531.014% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 113380.488% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -12351.743% |
| Notable Labs, Ltd. | 113 Thousand USD | -123205.31% |
| Liquidia Corporation | 14.6 Million USD | -854.349% |
| Mustang Bio, Inc. | -2.22 Million USD | 6362.247% |
| Immunovant, Inc. | -231 Thousand USD | 60418.182% |
| Quantum-Si incorporated | 488 Thousand USD | -28452.254% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 350.787% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 464550.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -7383.083% |
| Acasti Pharma Inc. | -11 Thousand USD | 1266781.818% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 68195.515% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 21587.26% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 183.179% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -12180.756% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 36670.866% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 7216.19% |
| PepGen Inc. | -1.18 Million USD | 11868.159% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 109812.598% |
| United Therapeutics Corporation | 2.07 Billion USD | 93.269% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 708.53% |
| Solid Biosciences Inc. | -76.56 Million USD | 281.987% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 168821.165% |
| Immuneering Corporation | -764.13 Thousand USD | 18334.272% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -210172.546% |
| Belite Bio, Inc | -399 Thousand USD | 35021.053% |
| XOMA Corporation | 3.86 Million USD | -3508.78% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 795.423% |
| Bionomics Limited | -434.44 Thousand USD | 32171.659% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 13073.464% |
| uniQure N.V. | 2.21 Million USD | -6190.519% |
| Cassava Sciences, Inc. | -89.42 Million USD | 255.816% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 251.338% |
| Forte Biosciences, Inc. | -9000.00 USD | 1548266.667% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 16786.826% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 31984.439% |
| Altimmune, Inc. | -65.37 Million USD | 313.138% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 61.513% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 13073.464% |
| Compugen Ltd. | 31.45 Million USD | -342.966% |
| Peak Bio, Inc. | 367.76 Thousand USD | -37786.554% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -468.343% |
| Benitec Biopharma Inc. | 108 Thousand USD | -128913.889% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 178734.615% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 11682.294% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 7747.366% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 117188.235% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 11682.294% |
| Instil Bio, Inc. | -4.75 Million USD | 3029.668% |
| argenx SE | 1.1 Billion USD | 87.43% |
| Immunome, Inc. | -8.9 Million USD | 1664.331% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 7472.222% |
| Verona Pharma plc | -679.62 Thousand USD | 20601.777% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 79720.0% |
| Shattuck Labs, Inc. | -2.38 Million USD | 5942.138% |
| CervoMed Inc. | -1.29 Million USD | 10870.879% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 5888.741% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 3016.789% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -5538.81% |
| Moolec Science SA | -143.3 Thousand USD | 97329.685% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 34248.224% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 5315.555% |
| Design Therapeutics, Inc. | -537 Thousand USD | 26046.927% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 32731.148% |
| NeurAxis, Inc. | 2.15 Million USD | -6360.553% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -6392.777% |
| Lumos Pharma, Inc. | 2 Million USD | -6842.451% |
| Achilles Therapeutics plc | -4.73 Million USD | 3044.983% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 79720.0% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 131952.378% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -340.115% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -16062.184% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 13601.453% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 405.908% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -323934.884% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 17050.73% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 1059037.528% |
| Palisade Bio, Inc. | 246 Thousand USD | -56540.244% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 422327.273% |
| Beam Therapeutics Inc. | -59.67 Million USD | 333.501% |
| Neurogene Inc. | -3.26 Million USD | 4371.459% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -248.338% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 47014.141% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 3559.988% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 1556.565% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -889.595% |
| Athira Pharma, Inc. | -969 Thousand USD | 14479.257% |
| Vaccinex, Inc. | -16 Million USD | 970.626% |
| HCW Biologics Inc. | -574.82 Thousand USD | 24339.593% |
| XOMA Corporation | 3.86 Million USD | -3508.78% |
| Nektar Therapeutics | 53.47 Million USD | -160.546% |
| Arvinas, Inc. | 71.8 Million USD | -94.06% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 266.946% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 321.959% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 43371.739% |
| Rezolute, Inc. | -36 Thousand USD | 387141.667% |
| Clene Inc. | 533 Thousand USD | -26041.651% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 10851735.514% |
| BeyondSpring Inc. | 1.75 Million USD | -7857.453% |
| Synlogic, Inc. | -1.92 Million USD | 7341.944% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 376681.081% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 2300.49% |
| Peak Bio, Inc. | 367.76 Thousand USD | -37786.554% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 834.773% |
| Krystal Biotech, Inc. | 47.6 Million USD | -192.69% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 1.245% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -2672.836% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 5481.352% |
| MannKind Corporation | 136.19 Million USD | -2.309% |
| Ikena Oncology, Inc. | -50.49 Million USD | 375.955% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -28.049% |
| Gossamer Bio, Inc. | -4.38 Million USD | 3277.537% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 55391.667% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 2786800.0% |
| Legend Biotech Corporation | 140.92 Million USD | 1.131% |
| Mural Oncology plc | -2.56 Million USD | 5527.931% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 25387.659% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 139435.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -571.365% |
| REGENXBIO Inc. | 53.02 Million USD | -162.752% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 2701.012% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 72528.85% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 8144.746% |
| Vaxart, Inc. | -60.76 Million USD | 329.309% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 53123.442% |
| Cellectis S.A. | 18 Thousand USD | -773983.333% |
| Longeveron Inc. | 221 Thousand USD | -62947.511% |
| Repare Therapeutics Inc. | -80.07 Million USD | 274.016% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 87.252% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 10867.774% |
| Revolution Medicines, Inc. | -399.66 Million USD | 134.863% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 398200.0% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -284257.143% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 98.381% |
| Denali Therapeutics Inc. | -93.34 Million USD | 249.269% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 556349.75% |
| Veru Inc. | 7.56 Million USD | -1741.611% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 92374.834% |
| Cingulate Inc. | -582.91 Thousand USD | 24003.019% |
| Passage Bio, Inc. | -3.72 Million USD | 3844.558% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 1156983.095% |
| Exicure, Inc. | -1.42 Million USD | 9891.637% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 36479.896% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -5054.828% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 27278.037% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -104.525% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 93234.011% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 335.339% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -35535.55% |
| OmniAb, Inc. | 14.66 Million USD | -849.99% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -596.919% |
| Lipocine Inc. | -2.85 Million USD | 4987.545% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 7660.228% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 2542.331% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 9350.205% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -85.001% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 214461.538% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -65.293% |
| Ocugen, Inc. | -33.53 Million USD | 515.466% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 4506.546% |
| Q32 Bio Inc. | 578 Thousand USD | -24006.401% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 52679.245% |
| Alumis Inc. Common Stock | -1.28 Million USD | 10951.636% |
| Equillium, Inc. | 35.95 Million USD | -287.494% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 8262.566% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -27729.208% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 3370564.441% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 53897.297% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -32862.159% |
| Dominari Holdings Inc. | 2.03 Million USD | -6733.497% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 76043.882% |
| vTv Therapeutics Inc. | -13.59 Million USD | 1124.899% |
| Bio-Techne Corporation | 773.07 Million USD | 81.976% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -704.521% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 69.761% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 12019.162% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 681.047% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -1091.203% |
| Nkarta, Inc. | -5.86 Million USD | 2474.084% |
| BioCardia, Inc. | -7.24 Million USD | 2022.127% |
| Iterum Therapeutics plc | -1.75 Million USD | 8062.0% |